Anti-vascular endothelial growth factor (anti-VEGF) agents have a broad field of application due to their impact on tumor growth and metastasis in oncology or in sealing, and antiangiogenic effect in the treatment of neovascular age-related macular degeneration (nAMD) or other retinal diseases. The gene discussed is VEGFA; the disease is neoplasm.